Jeffrey P. Ward

ChemistryMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study”.

Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study

The Lancet Oncology(2023)10.1016/s1470-2045(23)00344-3

N/A

3.1DataRank · unranked

105 citations

Rupesh Kotecha, Rodryg Ramlau, Li Zhang, Janusz Milanowski, Manuel Cobo +20 more

Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma

Blood(2021)10.1182/blood.2021011894

N/A

1.2DataRank · unranked

35 citations

Melissa M. Berrien-Elliott, Felicia Gomez, Jingqin Luo, Michelle Becker‐Hapak, Amanda F. Cashen +15 more

Bcl6-Independent In Vivo Development of Functional Type 1 Classical Dendritic Cells Supporting Tumor Rejection

The Journal of Immunology(2021)10.4049/jimmunol.1901010

N/A

0DataRank · unranked

6 citations

Kevin O’Connor, Renee Wu, Stephen T. Ferris, Jeffrey P. Ward, Robert D. Schreiber +3 more

BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-0129

N/A

0DataRank · unranked

48 citations

Alexander S. Shavkunov, Qi Miao, Nicholas N. Jarjour, Sunita Keshari, Ekaterina Esaulova +9 more

1006 High doses of MHC-II neoantigens in peptide cancer vaccines induce tumor-specific inhibitory cytolytic CD4+T cells

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.1006

N/A

0DataRank · unranked

0 citations

Yoshiko Takeuchi, Jeffrey P. Ward, Maria Firulyova, Tiantian Liu, Naveen Sharma +16 more

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

Cell(2020)10.1016/j.cell.2020.09.015

N/A

0DataRank · unranked

541 citations

Marit M. van Buuren, Kristen K. Dang, Vanessa M. Hubbard-Lucey, Kathleen C. F. Sheehan, Katie M. Campbell +95 more

The influence of body mass index on Tumor Treating Fields therapy in patients with metastatic non-small cell lung cancer: A post-hoc and simulation analysis from the phase III LUNAR study

Lung Cancer(2025)10.1016/j.lungcan.2025.108802

N/A

0DataRank · unranked

1 citations

David E. Gerber, Rupesh Kotecha, Jeffrey P. Ward, Wallace Akerley, Lukas Weiß +5 more

Radiation-induced neoantigens broaden the immunotherapeutic window of cancers with low mutational loads

Proceedings of the National Academy of Sciences(2021)10.1073/pnas.2102611118

N/A

0DataRank · unranked

136 citations

Elise Alspach, Jeffrey P. Ward, Alexander P. Miceli, Daniele Runci, J. Michael White +8 more